Search

Displaying results 7091 - 7100 of 8573 in total
  1. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure

  2. Drug

    Trodusquemine

    go.drugbank.com/drugs/DB06333
    Investigational

    It has demonstrated the ability to stimulate regeneration of heart and multiple other tissues in animal models [A176600].

  3. Drug

    2'-fluoro-5-ethylarabinosyluracil

    go.drugbank.com/drugs/DB13030
    Investigational

    2'-fluoro-5-ethylarabinosyluracil (FAU) has been used in trials studying the treatment of Small Intestine Lymphoma, Stage IV Mantle Cell Lymphoma, Waldenström Macroglobulinemia, Splenic Marginal Zone Lymphoma

  4. Drug

    CDX-1135

    go.drugbank.com/drugs/DB17607
    Investigational

    It was investigated in clinical trials for post-cardiopulmonary bypass syndrome and kidney damage.

  5. Drug

    Detirelix

    go.drugbank.com/drugs/DB19488
    Experimental

    Detirelix has a monoisotopic molecular weight of 1536.78 Da.

  6. Drug

    Terdecamycin

    go.drugbank.com/drugs/DB19720
    Experimental

    Terdecamycin has a monoisotopic molecular weight of 585.31 Da.

  7. Drug

    Peforelin

    go.drugbank.com/drugs/DB21255
    Experimental

    Peforelin has a monoisotopic molecular weight of 1258.56 Da.

  8. Drug

    Sornidipine

    go.drugbank.com/drugs/DB21432
    Experimental

    Sornidipine has a monoisotopic molecular weight of 460.15 Da.

  9. Drug

    Polvitolimod

    go.drugbank.com/drugs/DB21548
    Experimental

    Polvitolimod has a monoisotopic molecular weight of 323.1 Da.

  10. Drug

    Talogreptide mesaroxetan

    go.drugbank.com/drugs/DB21743
    Experimental

    Talogreptide mesaroxetan has a monoisotopic molecular weight of 1769.07 Da.